A DECOMPOSITION PRODUCT OF A CONTAMINANT IMPLICATED IN L-TRYPTOPHAN EOSINOPHILIA-MYALGIA-SYNDROME AFFECTS SPINAL-CORD NEURONAL CELL-DEATH AND SURVIVAL THROUGH STEREOSPECIFIC, MATURATION AND PARTLY INTERLEUKIN-1-DEPENDENT MECHANISMS
De. Brenneman et al., A DECOMPOSITION PRODUCT OF A CONTAMINANT IMPLICATED IN L-TRYPTOPHAN EOSINOPHILIA-MYALGIA-SYNDROME AFFECTS SPINAL-CORD NEURONAL CELL-DEATH AND SURVIVAL THROUGH STEREOSPECIFIC, MATURATION AND PARTLY INTERLEUKIN-1-DEPENDENT MECHANISMS, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 1029-1035
The L-tryptophan eosinophilia myalgia syndrome (L-TRP-EMS), an inflamm
atory syndrome characterized by eosinophilia, myalgias, perimyositis,
fasciitis and neuropathies, occurred in epidemic proportions in the Un
ited States in the summer and fall of 1989. The neuropathic clinical f
eatures in L-TRP EMS are complex and mixed. In the present study, one
of the impurities most highly associated with development Of L-TRP EMS
, 1,1'-ethylidenebis[L-tryptophan] (EBT), and two of its diastereoisom
eric breakdown products, were compared for evidence of neurotoxicity i
n vitro. In 1-month-old spinal cord cultures derived from fetal mice,
synthetic (-)-(1S, hyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic
acid (1S-beta-C) produced a 30 to 35% loss in numbers of neurons. Toxi
city was not apparent after treatment with the R-isomer of the same co
mpound or with the parent compound, EBT. Cotreatment of cultures with
1S-beta-C and neutralizing antiserum to interleukin-1 alpha (IL-1 a),
or with 1 S-beta-C and neutralizing antiserum against the murine IL-1
receptor, prevented neuronal cell death associated with 1S-beta-C. Rec
ombinant IL-1 a also produced neuronal killing that was not additive t
o that observed with the 1S-beta-C treatment. In contrast, in immature
spinal cord neuronal cultures, the 1S-beta-C, but not the 1R-beta-C o
r EBT, prevented the 30% cell death which normally occurs in these cul
tures. Neither neutralizing anti-IL-1 antibody, nor anti-IL-1 receptor
antibody blocked the neuronal survival effect, suggesting that 1 S-be
ta-C induces neuronal survival through a receptor-mediated mechanism i
ndependent of IL-1. The stereospecificity suggests that these effects
may be receptor mediated. These studies indicate that the 1 S-beta-C e
ffects on neuronal survival in immature neurons are maturation-depende
nt, and that although the neurotoxic effects of 1 S-beta-C are recepto
r-mediated and linked to IL-1 alpha, the neuronal survival-promoting e
ffects are receptor-mediated and independent of IL-1. These data suppo
rt the hypothesis that 1S-beta-C can cause neuronal cell death, and im
ply that this compound may play a role in the etiology of some of the
neuropathic features Of L-TRP-EMS.